The British Journal of Psychiatry (1970) 117: 667-671. doi: 10.1192/bjp.117.541.667
© 1970 The Royal College of Psychiatrists
This Article
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by KAY, D. W. K.
Right arrow Articles by GARSIDE, R. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by KAY, D. W. K.
Right arrow Articles by GARSIDE, R. F.

A Seven-Month Double-Blind Trial of Amitriptyline and Diazepam in ECT-Treated Depressed Patients

D. W. K. KAY D.M., M.R.C.P., D.P.M.1, THOMAS FAHY M.D., D.P.M.2, and R. F. GARSIDE Ph.D., B.Sc., F.B.Ps.P.3

1 Consultant Psychiatrist and Honorary Lecturer, Royal Victoria Infirmary and University of Newcastle, Newcastle upon Tyne, NE1 4LP
2 Clinical Director, St. Loman's Hospital, Palmerstown, Co. Dublin
3 Senior Lecturer in Applied Psychology, Royal Victoria Infirmary and University of Newcastle, Newcastle upon Tyne, NE1 4LP

A `double-blind' trial designed to test the efficacy of amitriptyline over a seven month period was undertaken in 132 depressed patients treated with ECT. A control group selected at random was given diazepam. Both drugs were given from the commencement of ECT.

Progress was assessed (i) by recording `failures', i.e. drop outs from the trial, and the reasons for them; and (ii) by administering rating scales, on entry, and at one, four and seven months (a 5-grade clinical scale, the Hamilton scale, and two self-rating scales, the Beck and the Lubin).

In patients remaining on the drug at one month there was a significant advantage to the amitriptyline group on two of the four rating scales used. During the remainder of the trial fewer patients in this group committed suicide, had further ECT, or failed to improve. Side-effects, however, were more troublesome.

A possible depressant effect of diazepam is considered. The importance of maintenance therapy and of adequate supervision in the after-care of ECT treated depressive patients is indicated by the occurrence of three suicides in the group not receiving the anti-depressant drug.

Submitted on October 13, 1969




This article has been cited by other articles:


Home page
Arch Gen PsychiatryHome page
H. A. Sackeim, E. M. Dillingham, J. Prudic, T. Cooper, W. V. McCall, P. Rosenquist, K. Isenberg, K. Garcia, B. H. Mulsant, and R. F. Haskett
Effect of Concomitant Pharmacotherapy on Electroconvulsive Therapy Outcomes: Short-term Efficacy and Adverse Effects
Arch Gen Psychiatry, July 1, 2009; 66(7): 729 - 737.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
H. A. Sackeim, R. F. Haskett, B. H. Mulsant, M. E. Thase, J. J. Mann, H. M. Pettinati, R. M. Greenberg, R. R. Crowe, T. B. Cooper, and J. Prudic
Continuation Pharmacotherapy in the Prevention of Relapse Following Electroconvulsive Therapy: A Randomized Controlled Trial
JAMA, March 14, 2001; 285(10): 1299 - 1307.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
F. M. Quitkin
Placebos, Drug Effects, and Study Design: A Clinician's Guide
Am J Psychiatry, June 1, 1999; 156(6): 829 - 836.
[Abstract] [Full Text]


Home page
J PsychopharmacolHome page
A. L. Malizia and P. K. Bridges
The management of treatment-resistant affective disorder: clinical perspectives
J Psychopharmacol, January 1, 1992; 6(2): 145 - 155.
[PDF]


Home page
J PsychopharmacolHome page
S. A. Montgomery
Prophylaxis in recurrent unipolar depression: a new indication for treatment studies
J Psychopharmacol, January 1, 1989; 3(2): 47 - 53.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
J. M. Kane, F. M. Quitkin, A. Rifkin, J. R. Ramos-Lorenzi, D. D. Nayak, and A. Howard
Lithium Carbonate and Imipramine in the Prophylaxis of Unipolar and Bipolar II Illness: A Prospective, Placebo-Controlled Comparison
Arch Gen Psychiatry, September 1, 1982; 39(9): 1065 - 1069.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
A. Roy
Risk Factors for Suicide in Psychiatric Patients
Arch Gen Psychiatry, September 1, 1982; 39(9): 1089 - 1095.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
A. F. Schatzberg and J. O. Cole
Benzodiazepines in Depressive Disorders
Arch Gen Psychiatry, November 1, 1978; 35(11): 1359 - 1365.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
D. Avery and G. Winokur
Suicide, Attempted Suicide, and Relapse Rates in Depression: Occurrence After ECT and Antidepressant Therapy
Arch Gen Psychiatry, June 1, 1978; 35(6): 749 - 753.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
F. Quitkin, A. Rifkin, and D. F. Klein
Prophylaxis of Affective Disorders: Current Status of Knowledge
Arch Gen Psychiatry, March 1, 1976; 33(3): 337 - 341.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
A. Raskin, J. G. Schulterbrandt, N. Reatig, T. H. Crook, and D. Odle
Depression Subtypes and Response to Phenelzine, Diazepam, and a Placebo: Results of a Nine Hospital Collaborative Study
Arch Gen Psychiatry, January 1, 1974; 30(1): 66 - 75.
[Abstract] [PDF]